Los Angeles Capital Management LLC Has $745,000 Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Los Angeles Capital Management LLC trimmed its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 6.1% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 38,024 shares of the company’s stock after selling 2,484 shares during the period. Los Angeles Capital Management LLC’s holdings in Privia Health Group were worth $745,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Norges Bank acquired a new position in shares of Privia Health Group during the 4th quarter valued at about $27,959,000. Avidity Partners Management LP boosted its position in Privia Health Group by 43.1% during the third quarter. Avidity Partners Management LP now owns 1,545,100 shares of the company’s stock worth $35,537,000 after purchasing an additional 465,294 shares during the period. Riverbridge Partners LLC boosted its position in Privia Health Group by 8.7% during the fourth quarter. Riverbridge Partners LLC now owns 4,342,385 shares of the company’s stock worth $100,005,000 after purchasing an additional 348,852 shares during the period. Northern Trust Corp grew its holdings in Privia Health Group by 28.7% during the third quarter. Northern Trust Corp now owns 1,344,327 shares of the company’s stock valued at $30,920,000 after purchasing an additional 299,395 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Privia Health Group by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock valued at $259,740,000 after purchasing an additional 274,345 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $16.86 on Tuesday. The company’s fifty day moving average price is $17.57 and its two-hundred day moving average price is $19.90. The firm has a market capitalization of $2.01 billion, a PE ratio of 112.40, a price-to-earnings-growth ratio of 2.66 and a beta of 0.78. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $28.23.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, May 9th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). The business had revenue of $415.24 million during the quarter, compared to the consensus estimate of $435.07 million. Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. Analysts predict that Privia Health Group, Inc. will post 0.2 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on PRVA. Stifel Nicolaus lowered their target price on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Citigroup started coverage on Privia Health Group in a research note on Monday, April 22nd. They issued a “buy” rating and a $25.00 price objective on the stock. UBS Group decreased their target price on Privia Health Group from $31.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, March 1st. Baird R W raised Privia Health Group to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, JPMorgan Chase & Co. cut their price target on Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a report on Wednesday, March 6th. Two research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.92.

Insider Transactions at Privia Health Group

In related news, Director Adam Boehler purchased 277,565 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The shares were acquired at an average price of $16.17 per share, with a total value of $4,488,226.05. Following the purchase, the director now directly owns 5,488,701 shares in the company, valued at $88,752,295.17. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Thomas Bartrum sold 2,252 shares of the company’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $41,481.84. Following the sale, the executive vice president now owns 103,862 shares of the company’s stock, valued at approximately $1,913,138.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Adam Boehler purchased 277,565 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The shares were purchased at an average cost of $16.17 per share, with a total value of $4,488,226.05. Following the completion of the acquisition, the director now directly owns 5,488,701 shares in the company, valued at $88,752,295.17. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 293,235 shares of company stock valued at $4,745,481 and sold 49,390 shares valued at $897,700. 14.20% of the stock is currently owned by insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.